Source:http://linkedlifedata.com/resource/pubmed/id/15601628
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2004-12-16
|
pubmed:abstractText |
2-(p-amylcinnamoyl)amino-4-chlorobenzoic acid (PACA), pharmacological inhibitor of phospholipase A(2) (PLA(2)), inhibits epinephrine-stimulated thromboxane production in human platelets. In this study, we investigated the effect of PACA on meiotic maturation individually in stages V and VI oocytes. PACA prevented the maturation in stage V but merely delayed the process in stage VI oocytes. This was associated with the strong inhibition of Mos synthesis at both stages. Besides, PACA-induced inhibition of MAPK activation was evident in stage V but not in stage VI oocytes. PACA also inhibited the activation of Cdc2 kinase (Cdc2) in stage V but merely delayed the process in stage VI oocytes. Furthermore, 5 microM and higher concentrations of PACA completely inhibited the activation of MAPK and Cdc2 only in stage V, not in stage VI, oocytes. Moreover, we propose PACA as a new tool for the study of Xenopus oocyte maturation, which can also play a unique role for the studies of the stage-specific activation of MAPK and Cdc2.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2-(4-amylcinnamoyl)amino-4-chloroben...,
http://linkedlifedata.com/resource/pubmed/chemical/Aminobenzoic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/CDC2 Protein Kinase,
http://linkedlifedata.com/resource/pubmed/chemical/Cinnamates,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Mos protein, Xenopus,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-mos,
http://linkedlifedata.com/resource/pubmed/chemical/Xenopus Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0898-6568
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
507-23
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:15601628-Aminobenzoic Acids,
pubmed-meshheading:15601628-Animals,
pubmed-meshheading:15601628-Base Sequence,
pubmed-meshheading:15601628-CDC2 Protein Kinase,
pubmed-meshheading:15601628-Cinnamates,
pubmed-meshheading:15601628-Female,
pubmed-meshheading:15601628-Meiosis,
pubmed-meshheading:15601628-Mitogen-Activated Protein Kinases,
pubmed-meshheading:15601628-Molecular Sequence Data,
pubmed-meshheading:15601628-Oocytes,
pubmed-meshheading:15601628-Oogenesis,
pubmed-meshheading:15601628-Proto-Oncogene Proteins c-mos,
pubmed-meshheading:15601628-Xenopus,
pubmed-meshheading:15601628-Xenopus Proteins
|
pubmed:year |
2005
|
pubmed:articleTitle |
The distinct stage-specific effects of 2-(p-amylcinnamoyl)amino-4-chlorobenzoic acid on the activation of MAP kinase and Cdc2 kinase in Xenopus oocyte maturation.
|
pubmed:affiliation |
Division of Pathological Biochemistry, Department of Biomedical Sciences, School of Life Sciences, Faculty of Medicine, Tottori University, 86 Nishicho, Yonago 683-8503, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|